09:10 INNOMAXX BIOTEC<00340> - Unusual price movement The Stock Exchange has received a message from INNOMAXX Biotechnology Group Limited which is reproduced as follows:- "This statement is made at the request of The Stock Exchange of Hong Kong Limited. The Board of Directors (the "Board") of INNOMAXX Biotechnology Group Limited (the "Company") has noted the decrease in the price of the shares of the Company as at the date of this statement and wishes to state that the Board is not aware of any reasons for such decrease. Save for the announcement of the Company made on 1 April 2005, the Board confirms that there are no negotiations or agreements relating to intended acquisitions or realizations which are discloseable under Rule 13.23 of the Listing Rules, neither is the Board aware of any matter discloseable under the general obligation imposed by Rule 13.09 of the Listing Rules, which is or may be of a price sensitive nature. Made by the order of the Board of the Company, the directors of which individually and jointly accept responsibility for the accuracy of this statement. By Order of the Board Pang Kwei Ping Company Secretary Hong Kong, 4 April, 2005 As at the date hereof, the Board of Directors of the Company comprises Mr. Zhou Yucheng, Mr. Fu Weimin, Mr. Qi Xianchao and Mr. Zhao Linye as Executive Directors and Mr. Tang Tin Sek and Ms. Wang Yiming as Independent Non-executive Directors."